FDA
-
-
-
-
-
-
-
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
-
-
-
-
-
-
-
Emory University Hospital adopts Microbot Medical's robotic system
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Microbot Medical (MBOT)
-
-
-
-
-
-
-
Microbot Medical completes first closing of preferred option exercise
-
-
-
-
-
-
-
Microbot Medical receives FDA clearance for robotic surgery system
-
-
-
-
-
-
-
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
-
-
-
-
-
-
-
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

